NEVVI Medicare utilization intelligence
or

← back

Provider profile

ALLEN, EVERETT MD

Rheumatology · NPI 1609846641 · SAN ANTONIO, TX

1
Groups
48
Codes · 2024
220,914
Disclosed services

ALLEN, EVERETT is a Rheumatology in SAN ANTONIO, TX, a member of 1 medical group, who billed 48 distinct codes to Medicare Part B in 2024.

Groups: RHEUMATOLOGY ASSOCIATES OF SOUTH TEXAS, PLLC (SAN ANTONIO, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

220,914
disclosed services
48
codes billed to Medicare Part B
Prior year · CY2023 148,871 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3262 Injection, tocilizumab, 1 mg
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1602 Injection, golimumab, 1 mg, for intravenous use
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J3111 Injection, romosozumab-aqqg, 1 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J3247 Injection, secukinumab, intravenous, 1 mg
J1010 Injection, methylprednisolone acetate, 1 mg
J0897 Injection, denosumab, 1 mg
J9312 Injection, rituximab, 10 mg
J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80053 Blood test, comprehensive group of blood chemicals
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
86140 Measurement c-reactive protein for detection of infection or inflammation
86235 Measurement of antibody for assessment of autoimmune disorder, any method
96413 Administration of chemotherapy into vein, 1 hour or less
85652 Red blood cell sedimentation rate, to detect inflammation, automated
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J2919 Injection, methylprednisolone sodium succinate, 5 mg
83516 Analysis of substance using immunoassay technique, multiple step method
86225 Measurement of dna antibody, native or double stranded
86160 Measurement of complement (immune system proteins), antigen,
96415 Administration of chemotherapy into vein, each additional hour
86226 Measurement of dna antibody, single stranded
86431 Rheumatoid factor level
86200 Measurement of antibody for rheumatoid arthritis assessment
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
84550 Uric acid level, blood
82306 Vitamin d-3 level
J7323 Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
96375 Injection of additional new drug or substance into vein
82550 Creatine kinase (cardiac enzyme) level, total
82728 Ferritin (blood protein) level
83550 Iron binding capacity
J1030 Injection, methylprednisolone acetate, 40 mg
G0008 Administration of influenza virus vaccine
90653 Influenza vaccine, inactivated
82607 Cyanocobalamin (vitamin b-12) level
20600 Aspiration and/or injection of fluid from small joint
20610 Aspiration and/or injection of fluid from large joint
84443 Blood test, thyroid stimulating hormone (tsh)
20550 Injection into tendon or ligament
J1020 Injection, methylprednisolone acetate, 20 mg
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.